{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:53:54Z","timestamp":1787698434843,"version":"build-2784847793"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell&apos;Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009104","name":"University of Modena and Reggio Emilia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004770","name":"Universit\u00e0 degli Studi di Parma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004770","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Italian Association for Cancer Research","doi-asserted-by":"publisher","award":["IG25785"],"award-info":[{"award-number":["IG25785"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell&apos;Istruzione e del Merito","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejmech.2025.118056","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T15:18:10Z","timestamp":1755011890000},"page":"118056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Identification of pyrazolo-piperidinone derivatives targeting YAP-TEAD interface 3 as anticancer agents through integrated virtual screening and mass spectrometry proteomics"],"prefix":"10.1016","volume":"300","author":[{"given":"Laura","family":"Scalvini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Tagliazucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Marco","family":"Elisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Zappaterra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gaetana","family":"Moschella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Fantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Aiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remo","family":"Guerrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Albanese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Pacifico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Lopresti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Malpezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Saporito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Lamesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Losi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Mangani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Marverti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Venturelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glauco","family":"Ponterini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"D'Arca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Mor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0443-5402","authenticated-orcid":false,"given":"Maria Paola","family":"Costi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118056_bib1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3390\/pharmaceutics14020391","article-title":"Identification of a quinone derivative as a YAP\/TEAD activity modulator from a repurposing library","volume":"14","author":"Lauriola","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2025.118056_bib2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41392-022-01191-9","article-title":"The hippo signalling pathway and its implications in human health and diseases","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ejmech.2025.118056_bib3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nrc3458","article-title":"The hippo pathway and human cancer","volume":"13","author":"Harvey","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2025.118056_bib4","article-title":"The Hippo\/YAP signaling pathway: the driver of cancer metastasis","volume":"20","author":"Zhou","year":"2023","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.ejmech.2025.118056_bib5","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00432-018-2727-0","article-title":"The hippo pathway provides novel insights into lung cancer and mesothelioma treatment","volume":"144","author":"Liu","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118056_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13046-022-02377-3","article-title":"TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K\/AKT pathway in bladder cancer","volume":"41","author":"Chi","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118056_bib7","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1158\/1078-0432.CCR-13-3328","article-title":"An integrative analysis of the tumorigenic role of TAZ in human non\u2013small cell lung cancer","volume":"20","author":"Noguchi","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118056_bib8","first-page":"3870","article-title":"Gene silencing of transcription factor TEAD4 inhibits esophageal cancer cells by regulating TCF7","author":"He","year":"2020","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.ejmech.2025.118056_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.375","article-title":"Targeting hippo signaling in cancer: novel perspectives and therapeutic potential","volume":"4","author":"Lv","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.ejmech.2025.118056_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1101\/gad.1865810","article-title":"Structural insights into the YAP and TEAD complex","volume":"24","author":"Li","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2025.118056_bib11","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.bmcl.2019.06.022","article-title":"Structure-based design of potent linear peptide inhibitors of the YAP-TEAD protein-protein interaction derived from the YAP omega-loop sequence","volume":"29","author":"Furet","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ejmech.2025.118056_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1298","article-title":"Using <scp>PyMOL<\/scp> as a platform for computational drug design","volume":"7","author":"Yuan","year":"2017","journal-title":"WIREs Computational Molecular Science"},{"key":"10.1016\/j.ejmech.2025.118056_bib13","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.1038\/s41598-017-07632-8","article-title":"Verteporfin inhibits growth of human glioma in vitro without light activation","volume":"7","author":"Al-Moujahed","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118056_bib14","first-page":"27","article-title":"Verteporfin inhibits YAP function through up-regulating 14-3-3\u03c3 sequestering YAP in the cytoplasm","volume":"6","author":"Wang","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118056_bib15","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1002\/ijc.32667","article-title":"Verteporfin targeting YAP1\/TAZ\u2010TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells","volume":"146","author":"Giraud","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejmech.2025.118056_bib16","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1002\/cmdc.202100432","article-title":"Development of LM98, a small\u2010molecule TEAD inhibitor derived from flufenamic acid","volume":"16","author":"M\u00e9lin","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118056_bib17","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nchembio.2036","article-title":"Autopalmitoylation of TEAD proteins regulates transcriptional output of the hippo pathway","volume":"12","author":"Chan","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118056_bib18","doi-asserted-by":"crossref","first-page":"6744","DOI":"10.1038\/s41467-022-34559-0","article-title":"Pharmacological blockade of TEAD\u2013YAP reveals its therapeutic limitation in cancer cells","volume":"13","author":"Sun","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118056_bib19","first-page":"4399","article-title":"The novel potent TEAD inhibitor, K-975, inhibits YAP1\/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma","volume":"10","author":"Kaneda","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118056_bib20","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1021\/acs.jmedchem.2c01548","article-title":"Structure-based design of Y-shaped covalent TEAD inhibitors","volume":"66","author":"Lu","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118056_bib21","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78810","article-title":"Covalent disruptor of YAP-TEAD association suppresses defective Hippo signaling","volume":"11","author":"Fan","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.ejmech.2025.118056_bib22","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.TPS3168","article-title":"A phase 1, First-in-Human study of IK-930, an oral TEAD inhibitor targeting the Hippo pathway in subjects with advanced solid tumors","author":"Tolcher","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118056_bib23","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1158\/1535-7163.MCT-20-0717","article-title":"Small molecule inhibitors of TEAD auto-palmitoylation selectively inhibit proliferation and tumor growth of NF2 -deficient mesothelioma","volume":"20","author":"Tang","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ejmech.2025.118056_bib24","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/s43018-023-00577-0","article-title":"An allosteric pan-TEAD inhibitor blocks oncogenic YAP\/TAZ signaling and overcomes KRAS G12C inhibitor resistance","volume":"4","author":"Hagenbeek","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ejmech.2025.118056_bib25","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/S0959-8049(22)00906-6","article-title":"IK930, a novel TEAD inhibitor, sensitizes KRAS and EGFR mutant tumors to oncogene targeted therapy","volume":"174","author":"Rajurkar","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejmech.2025.118056_bib26","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41573-020-0070-z","article-title":"Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine","volume":"19","author":"Dey","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118056_bib27","article-title":"Direct inhibition of the YAP : TEAD interaction: an unprecedented drug discovery challenge","volume":"19","author":"Ch\u00e8ne","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118056_bib28","doi-asserted-by":"crossref","first-page":"17225","DOI":"10.1073\/pnas.0607171103","article-title":"Insights into transcription enhancer factor 1 (TEF-1) activity from the solution structure of the TEA domain","volume":"103","author":"Anbanandam","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2025.118056_bib29","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1096\/fj.14-262980","article-title":"Targeting Hippo pathway by specific interruption of YAP\u2010TEAD interaction using cyclic YAP\u2010like peptides","volume":"29","author":"Zhou","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.ejmech.2025.118056_bib30","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1021\/ml500160m","article-title":"Structure-based design and synthesis of potent cyclic peptides inhibiting the YAP\u2013TEAD protein\u2013protein interaction","volume":"5","author":"Zhang","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118056_bib31","series-title":"New Compounds Inhibitors of the yap\/taz-tead Interaction and their Use in the Treatment of Malignant Mesothelioma","author":"Barth","year":"2017"},{"key":"10.1016\/j.ejmech.2025.118056_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300051","article-title":"Optimization of a class of dihydrobenzofurane analogs toward orally efficacious YAP\u2010TEAD protein\u2010protein interaction inhibitors","volume":"18","author":"Sellner","year":"2023","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118056_bib33","article-title":"Direct and selective pharmacological disruption of the YAP\u2013TEAD interface by IAG933 inhibits Hippo-dependent and RAS\u2013MAPK-altered cancers","author":"Chapeau","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ejmech.2025.118056_bib34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13321-015-0069-3","article-title":"Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations?","volume":"7","author":"Bajusz","year":"2015","journal-title":"J. Cheminform."},{"key":"10.1016\/j.ejmech.2025.118056_bib35","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.cell.2012.11.026","article-title":"\u03b2-Catenin-Driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis","volume":"151","author":"Rosenbluh","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118056_bib36","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.celrep.2015.12.104","article-title":"Tead and AP1 coordinate transcription and motility","volume":"14","author":"Liu","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2025.118056_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109575","article-title":"YAP\/TEAD Co-Activator regulated pluripotency and chemoresistance in ovarian cancer initiated cells","volume":"9","author":"Xia","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118056_bib38","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41573-021-00240-2","article-title":"Ligand binding at the protein\u2013lipid interface: strategic considerations for drug design","volume":"20","author":"Payandeh","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118056_bib39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13321-018-0283-x","article-title":"ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database","volume":"10","author":"Dong","year":"2018","journal-title":"J. Cheminform."},{"key":"10.1016\/j.ejmech.2025.118056_bib40","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.3390\/molecules26195957","article-title":"Multi-targeted molecular docking, pharmacokinetics, and drug-likeness evaluation of okra-derived ligand abscisic acid targeting signaling proteins involved in the development of diabetes","volume":"26","author":"Ashraf","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118056_bib41","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.drudis.2021.02.003","article-title":"Benchmarking the mechanisms of frequent hitters: limitation of PAINS alerts","volume":"26","author":"Yang","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2025.118056_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113952","article-title":"One-pot three-component synthesis of novel pyrazolo[3,4-b]pyridines as potent antileukemic agents","volume":"227","author":"Barghash","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118056_bib43","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0014-5793(95)00062-E","article-title":"An exact mathematical expression for describing competitive binding of two different ligands to a protein molecule","volume":"360","author":"Wang","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2025.118056_bib44","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jpba.2017.11.014","article-title":"Fluorometric detection of protein-ligand engagement: the case of phosphodiesterase5","volume":"149","author":"Di Rocco","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejmech.2025.118056_bib45","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s42003-023-05331-x","article-title":"BRAFV600E-mutated serrated colorectal neoplasia drives transcriptional activation of cholesterol metabolism","volume":"6","author":"Rzasa","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejmech.2025.118056_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011837","article-title":"Establishment of protein delivery systems targeting podocytes","volume":"5","author":"Chiang","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118056_bib47","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1104829108","article-title":"Protein\u2013protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase","volume":"108","author":"Cardinale","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2025.118056_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1477318","article-title":"Enhanced anticancer effect of thymidylate synthase dimer disrupters by promoting intracellular accumulation","volume":"15","author":"Marverti","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118056_bib49","article-title":"YAP\/TAZ enhance P-body formation to promote tumorigenesis","author":"Shen","year":"2023","journal-title":"eLife12:RP88573"},{"key":"10.1016\/j.ejmech.2025.118056_bib50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13046-019-1217-9","article-title":"Aberrant activation of CYR61 enhancers in colorectal cancer development","volume":"38","author":"Xie","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118056_bib51","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1158\/2326-6066.CIR-19-0159","article-title":"Verteporfin inhibits PD-L1 through autophagy and the STAT1\u2013IRF1\u2013TRIM28 signaling axis, exerting antitumor efficacy","volume":"8","author":"Liang","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ejmech.2025.118056_bib52","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1186\/s12885-020-07555-0","article-title":"Verteporfin inhibits cell proliferation and induces apoptosis in different subtypes of breast cancer cell lines without light activation","volume":"20","author":"Wei","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejmech.2025.118056_bib53","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/pro.4218","article-title":"scp>PANTHER<\/scp> : making genome\u2010scale phylogenetics accessible to all","volume":"31","author":"Thomas","year":"2022","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2025.118056_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh1275","article-title":"Predicting and characterizing a cancer dependency map of tumors with deep learning","volume":"7","author":"Chiu","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2025.118056_bib55","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s13059-021-02540-7","article-title":"Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects","volume":"22","author":"Dempster","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.ejmech.2025.118056_bib56","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5604\/17322693.1094726","article-title":"SMAD family proteins: the current knowledge on their expression and potential role in neoplastic diseases","volume":"68","author":"Witkowska","year":"2014","journal-title":"Postepy Hig. Med. Dosw."},{"key":"10.1016\/j.ejmech.2025.118056_bib57","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1038\/s41467-018-04620-y","article-title":"SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity","volume":"9","author":"Yao","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118056_bib58","doi-asserted-by":"crossref","first-page":"D394","DOI":"10.1093\/nar\/gkaa1106","article-title":"PANTHER version 16: a revised family classification, tree-based classification tool, enhancer regions and extensive API","volume":"49","author":"Mi","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.118056_bib59","doi-asserted-by":"crossref","first-page":"11225","DOI":"10.1021\/ja9621760","article-title":"Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids","volume":"118","author":"Jorgensen","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.118056_bib60","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118056_bib61","series-title":"Schr\u00f6dinger Release 2024-2","year":"2024"},{"key":"10.1016\/j.ejmech.2025.118056_bib62","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1021\/acs.jctc.3c00044","article-title":"Epik: pKa and protonation state prediction through machine learning","volume":"19","author":"Johnston","year":"2023","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ejmech.2025.118056_bib63","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118056_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/0471250953.bi0812s18","article-title":"Flexible ligand docking with glide","volume":"18","author":"Repasky","year":"2007","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.ejmech.2025.118056_bib65","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1747-0285.2006.00384.x","article-title":"PHASE: a novel approach to pharmacophore modeling and 3D database searching","volume":"67","author":"Dixon","year":"2006","journal-title":"Chemical Biology & Drug Design"},{"key":"10.1016\/j.ejmech.2025.118056_bib66","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pep.2005.01.016","article-title":"Protein production by auto-induction in high-density shaking cultures","volume":"41","author":"Studier","year":"2005","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ejmech.2025.118056_bib67","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1021\/acs.jproteome.8b00235","article-title":"Comparison of in-solution, FASP, and S-Trap based digestion methods for Bottom-Up proteomic studies","volume":"17","author":"Ludwig","year":"2018","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ejmech.2025.118056_bib68","doi-asserted-by":"crossref","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","article-title":"UniProt: the universal protein knowledgebase in 2021","volume":"49","author":"Bateman","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.118056_bib69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/proteomes9010015","article-title":"Proteome discoverer\u2014A community enhanced data processing suite for protein informatics","volume":"9","author":"Orsburn","year":"2021","journal-title":"Proteomes"},{"key":"10.1016\/j.ejmech.2025.118056_bib70","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mas.21540","article-title":"The skyline ecosystem: informatics for quantitative mass spectrometry proteomics","volume":"39","author":"Pino","year":"2020","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.ejmech.2025.118056_bib71","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1042\/BCJ20180225","article-title":"Structural and ligand-binding analysis of the YAP-binding domain of transcription factor TEAD4","volume":"475","author":"Li","year":"2018","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2025.118056_bib72","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/sj.bjc.6605780","article-title":"5-Fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency","volume":"103","author":"Bracht","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmech.2025.118056_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103988","article-title":"Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes","volume":"9","author":"Beaufort","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118056_bib74","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.3390\/ijms20246122","article-title":"The 1,10-Phenanthroline ligand enhances the antiproliferative activity of DNA-intercalating Thiourea-Pd(II) and -Pt(II) complexes against cisplatin-sensitive and -Resistant human ovarian cancer cell lines","volume":"20","author":"Marverti","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118056_bib75","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods."},{"key":"10.1016\/j.ejmech.2025.118056_bib76","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/cancers15020412","article-title":"Serum mass spectrometry proteomics and protein set identification in response to FOLFOX-4 in drug-resistant ovarian carcinoma","volume":"15","author":"D'Arca","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejmech.2025.118056_bib77","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.aca.2019.08.032","article-title":"Filter aided sample preparation \u2013 a tutorial","volume":"1090","author":"Wi\u015bniewski","year":"2019","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ejmech.2025.118056_bib78","doi-asserted-by":"crossref","first-page":"D158","DOI":"10.1093\/nar\/gkw1099","article-title":"UniProt: the universal protein knowledgebase","volume":"45","author":"Consortium","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.118056_bib79","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nmeth.2557","article-title":"The CRAPome: a contaminant repository for affinity purification\u2013mass spectrometry data","volume":"10","author":"Mellacheruvu","year":"2013","journal-title":"Nat. Methods"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:49:36Z","timestamp":1772822976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425008219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":79,"alternative-id":["S0223523425008219"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118056","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of pyrazolo-piperidinone derivatives targeting YAP-TEAD interface 3 as anticancer agents through integrated virtual screening and mass spectrometry proteomics","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118056"}}